BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11509889)

  • 1. Characterization of permanent cell lines that contain the AAV2 rep-cap genes on an Epstein-Barr-virus-based episomal plasmid.
    Neyns B; Vermeij J; Teugels E; De Rijcke M; Hermonat P; De Grève J
    Intervirology; 2001; 44(4):255-63. PubMed ID: 11509889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap.
    Conway JE; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
    J Virol; 1997 Nov; 71(11):8780-9. PubMed ID: 9343238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient recombinant adeno-associated virus production by a stable rep-cap HeLa cell line correlates with adenovirus-induced amplification of the integrated rep-cap genome.
    Chadeuf G; Favre D; Tessier J; Provost N; Nony P; Kleinschmidt J; Moullier P; Salvetti A
    J Gene Med; 2000; 2(4):260-8. PubMed ID: 10953917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective Rep-Cap gene amplification as a mechanism for high-titer recombinant AAV production from stable cell lines.
    Liu X; Voulgaropoulou F; Chen R; Johnson PR; Clark KR
    Mol Ther; 2000 Oct; 2(4):394-403. PubMed ID: 11020356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replication of rep-cap genes is essential for the high-efficiency production of recombinant AAV.
    Fan PD; Dong JY
    Hum Gene Ther; 1997 Jan; 8(1):87-98. PubMed ID: 8989998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing recombinant adeno-associated virus production.
    Salvetti A; Orève S; Chadeuf G; Favre D; Cherel Y; Champion-Arnaud P; David-Ameline J; Moullier P
    Hum Gene Ther; 1998 Mar; 9(5):695-706. PubMed ID: 9551617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.
    Conway JE; Rhys CM; Zolotukhin I; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
    Gene Ther; 1999 Jun; 6(6):986-93. PubMed ID: 10455400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AAV production in stable packaging cells requires expression of adenovirus 22/33K protein to allow episomal amplification of integrated rep/cap genes.
    Su W; Seymour LW; Cawood R
    Sci Rep; 2023 Dec; 13(1):21670. PubMed ID: 38066084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rep/Cap gene amplification and high-yield production of AAV in an A549 cell line expressing Rep/Cap.
    Gao GP; Lu F; Sanmiguel JC; Tran PT; Abbas Z; Lynd KS; Marsh J; Spinner NB; Wilson JM
    Mol Ther; 2002 May; 5(5 Pt 1):644-9. PubMed ID: 11991756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfection-free and scalable recombinant AAV vector production using HSV/AAV hybrids.
    Booth MJ; Mistry A; Li X; Thrasher A; Coffin RS
    Gene Ther; 2004 May; 11(10):829-37. PubMed ID: 14985784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation and characterization of adeno-associated virus producer cell lines for research and preclinical vector production.
    Martin J; Frederick A; Luo Y; Jackson R; Joubert M; Sol B; Poulin F; Pastor E; Armentano D; Wadsworth S; Vincent K
    Hum Gene Ther Methods; 2013 Aug; 24(4):253-69. PubMed ID: 23848282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgene expression after rep-mediated site-specific integration into chromosome 19.
    Philpott NJ; Gomos J; Falck-Pedersen E
    Hum Gene Ther; 2004 Jan; 15(1):47-61. PubMed ID: 14965377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel tools for production and purification of recombinant adenoassociated virus vectors.
    Grimm D; Kern A; Rittner K; Kleinschmidt JA
    Hum Gene Ther; 1998 Dec; 9(18):2745-60. PubMed ID: 9874273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role for highly regulated rep gene expression in adeno-associated virus vector production.
    Li J; Samulski RJ; Xiao X
    J Virol; 1997 Jul; 71(7):5236-43. PubMed ID: 9188591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Construction of a hepatoma-targeting vector of adeno-associated virus containing human alpha-fetoprotein promoter and wild p53 gene in gene therapy of liver cancer].
    Cheng J; Leng X; Peng J
    Zhonghua Yi Xue Za Zhi; 2000 Jun; 80(6):461-3. PubMed ID: 11798803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A helper virus-free packaging system for recombinant adeno-associated virus vectors.
    Collaco RF; Cao X; Trempe JP
    Gene; 1999 Oct; 238(2):397-405. PubMed ID: 10570967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant adenovirus expressing adeno-associated virus cap and rep proteins supports production of high-titer recombinant adeno-associated virus.
    Zhang HG; Wang YM; Xie JF; Liang X; Hsu HC; Zhang X; Douglas J; Curiel DT; Mountz JD
    Gene Ther; 2001 May; 8(9):704-12. PubMed ID: 11406765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of adeno-associated virus packaging plasmids and cells that directly select for AAV helper functions.
    Whiteway A; Deru W; Prentice HG; Anderson R
    J Virol Methods; 2003 Dec; 114(1):1-10. PubMed ID: 14599673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of adenovirus-induced inverted terminal repeat-independent amplification of integrated adeno-associated virus rep-cap sequences.
    Tessier J; Chadeuf G; Nony P; Avet-Loiseau H; Moullier P; Salvetti A
    J Virol; 2001 Jan; 75(1):375-83. PubMed ID: 11119606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of recombinant adeno-associated virus vectors by a complete adenovirus-mediated approach.
    Zhang X; Li CY
    Mol Ther; 2001 May; 3(5 Pt 1):787-92. PubMed ID: 11356083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.